Flexibility is the name of the game: The Return podcast, episode 4
This article is part of a special podcast series that covers the challenges and opportunities of returning to the office. More from the series →
Subscribe: Apple Podcasts | Stitcher | Google Podcasts | Spotify
It’s been six months since Atlanta advertising agency Fitzco officially returned to the office. The team has weathered spikes in in-office Covid cases, blurring lines between work life and home life, and technological hiccups. But ultimately, it’s been a smooth transition.
In the final episode of The Return, we’ll do one more check-in with Fitzco staffers Erick Arenas, Bryce Burton, Jennifer “Jay Jay” Jones, and of course, CEO Dave Fitzgerald. We’ll also take a final look at what the future of work could be.
Digiday is proud to present The Return, a podcast about the advertising industry as it grapples with returning to the office in a global pandemic that has forced society to reconsider the very idea of work.
In four episodes, The Return follows Atlanta-based advertising agency Fitzco as the company returns to the office after a two-year-pandemic hiatus, answering questions about Covid-19 safety protocols amidst each new wave of the virus. It will also examine company culture, the push to change the future of work and what true work-life balance looks like.
The Return is hosted by McCoy and produced by Digiday audio producer Sara Patterson. Our script editor is Priya Rao. Subscribe to the Digiday podcast now on Apple Podcasts, or wherever you get your podcasts.
More in Marketing
Star power, AI jabs and Free Bird: Digiday’s guide to what was in and out at the Super Bowl
This year’s Big Game saw established brands lean heavily on star power, patriotic iconography and the occasional needle drop.
In Q1, marketers pivot to spending backed by AI and measurement
Q1 budget shifts reflect marketers’ growing focus on data, AI, measurement and where branding actually pays off.
GLP-1 draws pharma advertisers to double down on the Super Bowl
Could this be the last year Novo Nordisk, Boehringer Ingelheim, Hims & Hers, Novartis, Ro, and Lilly all run spots during the Big Game?